RhumbLine Advisers’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
65,407
+1,369
| +2% | +$8.57K | ﹤0.01% | 2805 |
|
|
2025
Q1 | $375K | Sell |
64,038
-9,581
| -13% | -$56.1K | ﹤0.01% | 2764 |
|
|
2024
Q4 | $605K | Sell |
73,619
-269
| -0.4% | -$2.21K | ﹤0.01% | 2543 |
|
|
2024
Q3 | $658K | Buy |
73,888
+10,405
| +16% | +$92.7K | ﹤0.01% | 2523 |
|
|
2024
Q2 | $480K | Buy |
63,483
+18,011
| +40% | +$136K | ﹤0.01% | 2709 |
|
|
2024
Q1 | $357K | Buy |
45,472
+5,589
| +14% | +$43.9K | ﹤0.01% | 2882 |
|
|
2023
Q4 | $353K | Sell |
39,883
-183
| -0.5% | -$1.62K | ﹤0.01% | 2871 |
|
|
2023
Q3 | $359K | Buy |
40,066
+389
| +1% | +$3.49K | ﹤0.01% | 2826 |
|
|
2023
Q2 | $490K | Buy |
39,677
+9,890
| +33% | +$122K | ﹤0.01% | 2701 |
|
|
2023
Q1 | $276K | Buy |
29,787
+7,117
| +31% | +$65.9K | ﹤0.01% | 2642 |
|
|
2022
Q4 | $238K | Buy |
22,670
+331
| +1% | +$3.48K | ﹤0.01% | 2743 |
|
|
2022
Q3 | $405K | Buy |
22,339
+1,626
| +8% | +$29.5K | ﹤0.01% | 2593 |
|
|
2022
Q2 | $294K | Buy |
+20,713
| New | +$294K | ﹤0.01% | 2764 |
|